(Q51186873)

1 April 2018

title

The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. (English)

1 reference

1 April 2018

1 reference

P Tyrer

1

1 reference

1 April 2018

N Seivewright

2

1 reference

1 April 2018

S Murphy

3

1 reference

1 April 2018

B Ferguson

4

1 reference

1 April 2018

D Kingdon

5

1 reference

1 April 2018

P Barczak

6

1 reference

1 April 2018

J Brothwell

7

1 reference

1 April 2018

C Darling

8

1 reference

1 April 2018

S Gregory

9

1 reference

1 April 2018

A L Johnson

10

1 reference

1 April 2018

language of work or name

English

0 references

publication date

1 July 1988

1 reference

1 April 2018

published in

The Lancet

1 reference

1 April 2018

volume

2

1 reference

1 April 2018

issue

8605

1 reference

1 April 2018

page(s)

235-240

1 reference

1 April 2018

Psychiatric reaction patterns to imipramine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Panic disorders: current perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Current concepts in psychiatry. Panic attacks and phobias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Neurotic illness and its response to anxiolytic and antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Short-term analytically oriented psychotherapy versus behavior therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

A preliminary investigation of cognitive and relaxation treatment of panic disorder: effects on intense anxiety vs 'background' anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Anxiety management for persistent generalised anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Psychiatric clinics in general practice. An extension of community care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

1 reference

7 January 2021

Scaling of Life Events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Classification of Personality Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Prediction of tricyclic antidepressant response: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

The effects of non-prescribing of anxiolytics in general practice. I. Controlled evaluation of psychiatric and social outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992535-4

7 January 2021

10.1016/S0140-6736(88)92535-4

Identifiers

DOI

1 reference

1 April 2018

1 reference

1 April 2018